Comorbidities in pregnant South African women living with HIV and associations with adverse birth outcomes: a prospective cohort study
- PMID: 40898079
- PMCID: PMC12406354
- DOI: 10.1186/s12884-025-08086-x
Comorbidities in pregnant South African women living with HIV and associations with adverse birth outcomes: a prospective cohort study
Abstract
Background: Despite improved health and survival due to lifelong antiretroviral therapy (ART), women living with HIV (WHIV) still face lower life expectancy, partly due to increased non-communicable disease (NCD) risk. Both HIV and NCDs are linked to adverse birth outcomes, yet data on their combined impact are limited. We investigated NCD burden by HIV status and compared adverse birth outcomes in pregnant WHIV only versus HIV-NCD comorbidity in Cape Town, South Africa.
Methods: Pregnant WHIV (n = 479) and without HIV (n = 510) were enrolled and prospectively followed for pregnancy outcome. Weight and height measurements were serially collected by a study nurse, and diagnoses of hypertension and diabetes mellitus (DM) were made by healthcare providers as part of routine care (ANC). Birth outcomes were abstracted from health records. Proportions described adverse outcomes between groups. Logistic regression was used to estimate associations between HIV and HIV-NCD with small for gestational age (SGA), large for gestational age (LGA), preterm delivery (PTD), low birthweight (LBW), and high birthweight (HBW) (reference: group with neither HIV nor NCDs).
Results: Among 989 pregnant women, 48% (n = 479) with HIV (median age 29 years, IQR 25-34), the prevalence of obesity (BMI ≥ 30 kg/m2) was 43%, hypertension 15% and DM 2%. The NCD prevalence did not differ by HIV status. HIV co-occurred with obesity in 31% of pregnancies, with hypertension in 5% and with DM in 0.2%. HIV with hypertension and HIV with hypertension and obesity were associated with increased odds of PTD compared to those with neither HIV-NCD (aOR 3.03, 95% CI 1.01, 8.05 and aOR 2.67, 95% CI 1.08, 6.23, respectively). However, HIV and obesity together were associated with lower odds of SGA (aOR 0.39, 95% CI 0.16, 0.97). Likewise, in women without HIV, obesity protected against SGA and LBW, but hypertension increased PTD and LBW.
Conclusion: There was no difference in the prevalence of NCD in pregnant women by HIV status. Increased risk of adverse birth outcomes was demonstrated with concurrent NCD regardless of HIV status. Integration of NCD screening and management within ANC could minimise excess adverse outcomes in high HIV burden settings.
Keywords: Adverse birth outcomes; Diabetes; HIV; Hypertension; Obesity; Pregnancy.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study followed the guidelines laid down in the Declaration of Helsinki, and all procedures involving research study participants were approved by relevant ethical bodies. The current study analysed data from a parent study titled B Positive. Since the study is a secondary research analysis, there was no requirement for obtaining informed consent, as participants had already consented that their information could be used for research and academic purposes. The University of Cape Town Human Research Ethics Committee had approved the parent study (HREC 541/2015) as well as the Western Cape Department of Health (REFWC_2016RP6_286). This current study sought ethical clearance from the University of Cape Town Human Research Ethics Committee (HREC 345/2022). All participants provided written informed consent prior to study participation. Consent for publication: Not applicable Competing interests: The authors declare no competing interests.
Figures




Similar articles
-
Metformin for women who are overweight or obese during pregnancy for improving maternal and infant outcomes.Cochrane Database Syst Rev. 2018 Jul 24;7(7):CD010564. doi: 10.1002/14651858.CD010564.pub2. Cochrane Database Syst Rev. 2018. PMID: 30039871 Free PMC article.
-
Multiple-micronutrient supplementation for women during pregnancy.Cochrane Database Syst Rev. 2017 Apr 13;4(4):CD004905. doi: 10.1002/14651858.CD004905.pub5. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 Mar 14;3:CD004905. doi: 10.1002/14651858.CD004905.pub6. PMID: 28407219 Free PMC article. Updated.
-
Techniques of monitoring blood glucose during pregnancy for women with pre-existing diabetes.Cochrane Database Syst Rev. 2017 Jun 11;6(6):CD009613. doi: 10.1002/14651858.CD009613.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2019 May 23;5:CD009613. doi: 10.1002/14651858.CD009613.pub4. PMID: 28602020 Free PMC article. Updated.
-
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18. Am J Obstet Gynecol MFM. 2022. PMID: 35728780
-
Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.Cochrane Database Syst Rev. 2010 Mar 17;2010(3):CD008440. doi: 10.1002/14651858.CD008440. Cochrane Database Syst Rev. 2010. PMID: 20238370 Free PMC article.
References
-
- Nnyepi MS, Gwisai N, Lekgoa M, Seru T. Evidence of nutrition transition in Southern Africa. Proc Nutr Soc. 2015;74(4):478–86. - PubMed
-
- National Department of Health (NDoH). Statistics South Africa (Stats SA), South African medical research Council (SAMRC), and ICF. South Africa demographic and health survey 2016. Maryland, USA: Pretoria, South Africa and Rockville; 2019.
-
- Hoffman RM, Newhouse C, Chu B, Stringer JS, Currier JS. Non-communicable diseases in pregnant and postpartum women living with HIV: implications for health throughout the life course. Curr HIV AIDS Rep. 2021;18:73–86. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical